Related Experiment Video
Updated: Apr 15, 2026

Protocol for Microplastics Sampling on the Sea Surface and Sample Analysis
Published on: December 16, 2016
Microplastics and pathogen risk across ecosystems: From biofilm to antimicrobial resistance and host susceptibility
Feroz Ahmad1, Chao Sun2, Abrar Muhammad1
1Institute of Sericulture and Apiculture, Faculty of Agriculture, Life and Environmental Sciences, Zhejiang University, Hangzhou, 310058, China.
Abstract:
Microplastics (MPs) are ubiquitous in terrestrial and aquatic ecosystems, where they rapidly acquire organic coatings and biofilms (the plastisphere) and interact with co-occurring chemical pollutants. However, the conditions under which MPs become ecologically relevant in increasing disease risk remain underexplored. A key controversy is that microbial detection or enrichment on MPs is often treated as evidence of pathogen "vectoring," yet most studies do not quantify viability/infectivity, detachment, or delivered dose to hosts under environmentally realistic conditions. This review synthesizes evidence on MP-pathogen interactions and dispersal across ecosystems and reframes "MPs as vectors" through a vectorial-capacity lens that distinguishes association from transmission relevance and links MP-mediated risk to measurable dose delivery at host-relevant interfaces. Across ecosystems, evidence supports biofilm-driven persistence and enrichment of opportunistic taxa, but direct demonstrations of MP-mediated infection remain limited. We further highlight an unresolved issue, whether MPs confer unique transmission advantages compared with size-matched natural particulates that also sorb microbes and contaminants but are rarely used as comparators. We examine host susceptibility as a risk multiplier: MP exposure can compromise epithelial barriers via oxidative stress, modulate innate immunity, and disrupt microbiome-mediated colonization resistance. Plastisphere biofilms may also function as eco-evolutionary microhabitats that enrich antibiotic-resistant bacteria (ARB) and antibiotic resistance genes (ARGs), with plausible enhancement of horizontal gene transfer, although field-scale attribution is still scarce. Finally, we outline priorities for standardized evidence grading, comparator-based study designs, and quantitative metrics (loading, viability decay, detachment kinetics) to enable risk attribution and guide monitoring and mitigation.
Insights
Microplastics (MPs) can carry microbes, but evidence for them increasing disease risk is limited. Further research is needed to quantify MP-pathogen interactions and transmission under realistic conditions.
Area of Science:
- Environmental Science
- Microbiology
- Ecotoxicology
Background:
- Microplastics (MPs) contaminate ecosystems, forming biofilms (plastisphere) and interacting with pollutants.
- The role of MPs in disease transmission and pathogen vectoring is debated, with limited data on viability and dose delivery.
- Host susceptibility can be increased by MP exposure, affecting immunity and microbiome.
Purpose of the Study:
- To review evidence on microplastic-pathogen interactions and dispersal.
- To reframe MP vectoring through a vectorial-capacity lens, focusing on dose delivery.
- To identify research gaps and propose priorities for risk assessment.
Main Methods:
- Literature synthesis of MP-pathogen interactions across ecosystems.
- Analysis of evidence for MP-mediated pathogen persistence, enrichment, and transmission.
- Examination of host susceptibility factors and eco-evolutionary aspects of the plastisphere.
Main Results:
- Biofilms on MPs support microbial persistence and opportunistic taxa enrichment.
- Direct evidence for MP-mediated infection is limited; comparator studies are scarce.
- Plastisphere biofilms may enrich antibiotic-resistant bacteria and genes, potentially enhancing HGT.
Conclusions:
- Current evidence does not strongly support MPs as significant disease vectors.
- Standardized metrics and comparator-based designs are crucial for accurate risk assessment.
- Further research should focus on quantitative dose delivery and field-scale attribution of MP-mediated risks.
Related Concept Videos
Biofilms
Introduction to the Human Microbiota
Clinical Significance of Antibiotic Resistance
Colonisation of Pathogens
The Oral Microbiota
Microbial Corrosion

